Characterization of drug-resistant cell lines by comparative genomic hybridization

被引:14
作者
Carlson, KM
Gruber, A
Liliemark, E
Larsson, R
Nordenskjöld, M
机构
[1] Karolinska Hosp, Dept Mol Med, Clin Genet Unit, S-17176 Stockholm, Sweden
[2] Karolinska Hosp, Dept Hematol & Infect Dis, S-17176 Stockholm, Sweden
[3] Karolinska Hosp, Dept Pathol & Oncol, S-17176 Stockholm, Sweden
[4] Uppsala Univ, Dept Clin Pharmacol, Uppsala, Sweden
关键词
D O I
10.1016/S0165-4608(98)00222-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The development of resistance to cytostatic agents is a serious obstacle to the success of cancer therapy and has been the focus of many research efforts. Traditionally, cell lines are selectively cultured in the presence of cytostatic agents and the biochemical and cytogenetic properties of the cell lines are then analyzed. In order to better understand the mechanisms by which drug resistance is mediated, we have analyzed three cell lines, each derived from the parent line K562, which are resistant to vincristine, mitoxantrone, or idarubicin, using comparative genomic hybridization (CGN), in each case, CGH successfully identified amplifications and/or deletions unique to the drug-resistant selected cell lines. Further characterization of the generic regions identified in the CGH analysis could greatly contribute to our understanding of acquired drug resistance, and could potentially impact the clinical management of cancer. (C) Elsevier Science Inc., 1999. All rights reserved.
引用
收藏
页码:32 / 36
页数:5
相关论文
共 23 条
[1]   OVERPRODUCTION OF THE FREE-RADICAL OF RIBONUCLEOTIDE REDUCTASE IN HYDROXYUREA-RESISTANT MOUSE FIBROBLAST 3T6-CELLS [J].
AKERBLOM, L ;
EHRENBERG, A ;
GRASLUND, A ;
LANKINEN, H ;
REICHARD, P ;
THELANDER, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (04) :2159-2163
[2]  
ASK A, 1993, CANCER RES, V53, P5262
[3]  
Banerjee D, 1995, ACTA BIOCHIM POL, V42, P457
[4]  
BERGER SH, 1985, MOL PHARMACOL, V28, P461
[5]  
CLARK JL, 1987, CANCER TREAT REP, V71, P261
[6]   Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance [J].
Dhar, S ;
Nygren, P ;
Csoka, K ;
Botling, J ;
Nilsson, K ;
Larsson, R .
BRITISH JOURNAL OF CANCER, 1996, 74 (06) :888-896
[7]   DETECTION OF COMPLETE AND PARTIAL CHROMOSOME GAINS AND LOSSES BY COMPARATIVE GENOMIC INSITU HYBRIDIZATION [J].
DUMANOIR, S ;
SPEICHER, MR ;
JOOS, S ;
SCHROCK, E ;
POPP, S ;
DOHNER, H ;
KOVACS, G ;
ROBERTNICOUD, M ;
LICHTER, P ;
CREMER, T .
HUMAN GENETICS, 1993, 90 (06) :590-610
[8]   BIOCHEMISTRY OF MULTIDRUG-RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER [J].
GOTTESMAN, MM ;
PASTAN, I .
ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :385-427
[9]   QUANTITATIVE-DETERMINATION OF MDR1 GENE-EXPRESSION IN LEUKEMIC-CELLS FROM PATIENTS WITH ACUTE-LEUKEMIA [J].
GRUBER, A ;
VITOLS, S ;
NORGREN, S ;
ARESTROM, I ;
PETERSON, C ;
BJORKHOLM, M ;
REIZENSTEIN, P ;
LUTHMAN, H .
BRITISH JOURNAL OF CANCER, 1992, 66 (02) :266-272
[10]  
HegewischBecker S, 1996, LEUKEMIA, V10, pS32